评估AMR活动成本效益的挑战:政策制定者的考虑
Mary Jordan1, Abimbola Ayorinde1, Iman Ghosh1
1Warwick Medical School, University of Warwick, Coventry, UK.
Public health
|August 3, 2025
概括
由于方法上的局限性,评估抗菌素耐药性 (AMR) 运动的成本效益具有挑战性. 政策制定者需要更好的证据来证明对抗AMR的投资是合理的.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 传染病控制和控制传染病
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁.
- 评估AMR干预措施的经济影响对于资源分配至关重要.
- 公共卫生活动对抗抗菌素耐药性至关重要,但其成本效益难以衡量.
研究的目的:
- 审查 AMR 运动的成本效益评估中的挑战.
- 为决策者提供有关AMR干预措施证据评估的信息.
- 为了突出考虑未来的经济评估.
主要方法:
- 基于成本效益分析的快速审查的政策评论.
- 对评估公共卫生活动的方法进行了广泛的文献搜索.
- 对抗药物耐药性干预措施的经济评估存在挑战的分析.
主要成果:
- 在测量AMR运动的临床和社会结果方面仍然存在重大方法挑战.
- 捕捉长期影响和与AMR相关的全部成本仍然很困难.
- 二十年来,成本效益方法的进展有限,阻碍了政策决策.
结论:
- 由于方法上的差距,政策制定者难以证明投资AMR活动的合理性.
- 需要改进的方法来确定公共AMR干预措施的成本效益.
- 抗菌药物耐药性运动的社会价值强调了需要强有力的经济证据来支持政策的必要性.
更多相关视频
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
14.4K
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.7K
相关概念视频
Antimicrobial Effectiveness
159
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
159
Development of Antibiotic Resistance
203
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
203
Antibiotic Selection
55.3K
Overview
55.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Drug Control Governance: Regulatory Bodies and Their Impact
246
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
246
